Dr. G. Pompei

Graziella Pompei

Interventional cardiologist / Cardiologist
Hospital Santa Maria delle Croci - Ravenna, Italy

Latest contributions

Navigating complexity in high-risk patients with multivessel disease undergoing PCI

23 May 2025 – From EuroPCR 2025

This educational session focuses on navigating the complexities of PCI in high-risk patients with multivessel disease. Learn the roles of imaging and physiology, low-contrast PCI techniques, and optimal strategies for patients with concomitant aortic stenosis, illustrated through detailed case discussions.

Navigating complexity in high-risk patients with multivessel disease undergoing PCI

Coronary protection during native and valve-in-valve TAVI

22 May 2025 – From EuroPCR 2025

Understand the critical role of coronary protection during native and valve-in-valve transcatheter aortic valve implantation (TAVI). This session covers procedural planning essentials, the impact of upfront coronary protection, challenges in coronary obstruction diagnosis, and the use of guide catheter extension to facilitate protection during TAVI procedures.

Coronary protection during native and valve-in-valve TAVI

Management of MINOCA patients

15 May 2024 – From EuroPCR 2024

Management of MINOCA patients

Artificial intelligence-powered quantification of coronary physiology and vulnerable plaque: opportunities for novel treatment options

15 May 2024 – From EuroPCR 2024

In this session, uncover new data on Murray-law based quantitative flow ratio (muFR) assessment, providing a comprehensive understanding of PCI outcomes from a single angiographic view, explore the innovative application of artificial intelligence in identifying vulnerable plaque and assessing hemodynamic stenosis significance through the analysis of...

Artificial intelligence-powered quantification of coronary physiology and vulnerable plaque: opportunities for novel treatment options

EuroPCR 2023 Hotlines/Late-Breaking Trials: focus on stent technology

17 May 2023 – From EuroPCR 2023

If you would like to learn more about the latest findings on stent techhnology, check-out this session in which speakers reviewed a series of recent trials, among them: 12-month primary endpoint outcomes of the BIOADAPTOR-RCT; Final 5-year results from the blinded ABSORB IV trial ; BIOMAG-I:...

Late breaking trials on stent technology